List of Tables

Table 1. Anticoagulant Injections Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Anticoagulant Injections Market Restraints

Table 3. Anticoagulant Injections Market Trends

Table 4. Anticoagulant Injections Industry Policy

Table 5. Global Anticoagulant Injections Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Anticoagulant Injections Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Anticoagulant Injections Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Anticoagulant Injections Mergers & Acquisitions, Expansion Plans

Table 9. Global Anticoagulant Injections Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Anticoagulant Injections Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 12. China Anticoagulant Injections Revenue Market Share by Company, 2020-2025

Table 13. Global Key Players of Anticoagulant Injections Upstream (Raw Materials)

Table 14. Global Anticoagulant Injections Typical Customers

Table 15. Anticoagulant Injections Typical Distributors

Table 16. by Type, Global Anticoagulant Injections Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 17. by Application, Global Anticoagulant Injections Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 18. By Region, Global Anticoagulant Injections Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 19. By Region, Global Anticoagulant Injections Consumption Value, 2020-2031, US$ Million

Table 20. By Country, Global Anticoagulant Injections Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 21. By Country, Global Anticoagulant Injections Consumption Value, 2020-2031, US$ Million

Table 22. By Country, Global Anticoagulant Injections Consumption Value Market Share, 2020-2031

Table 23. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 24. Sanofi Company Profile and Main Business

Table 25. Sanofi Anticoagulant Injections Models, Specifications, and Application

Table 26. Sanofi Anticoagulant Injections Revenue and Gross Margin, US$ Million, 2020-2025

Table 27. Sanofi Recent Developments

Table 28. Genentech (Roche) Company Information, Head Office, Market Area, and Industry Position

Table 29. Genentech (Roche) Company Profile and Main Business

Table 30. Genentech (Roche) Anticoagulant Injections Models, Specifications, and Application

Table 31. Genentech (Roche) Anticoagulant Injections Revenue and Gross Margin, US$ Million, 2020-2025

Table 32. Genentech (Roche) Recent Developments

Table 33. Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position

Table 34. Boehringer Ingelheim Company Profile and Main Business

Table 35. Boehringer Ingelheim Anticoagulant Injections Models, Specifications, and Application

Table 36. Boehringer Ingelheim Anticoagulant Injections Revenue and Gross Margin, US$ Million, 2020-2025

Table 37. Boehringer Ingelheim Recent Developments

Table 38. Aspen Company Information, Head Office, Market Area, and Industry Position

Table 39. Aspen Company Profile and Main Business

Table 40. Aspen Anticoagulant Injections Models, Specifications, and Application

Table 41. Aspen Anticoagulant Injections Revenue and Gross Margin, US$ Million, 2020-2025

Table 42. Aspen Recent Developments

Table 43. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 44. Pfizer Company Profile and Main Business

Table 45. Pfizer Anticoagulant Injections Models, Specifications, and Application

Table 46. Pfizer Anticoagulant Injections Revenue and Gross Margin, US$ Million, 2020-2025

Table 47. Pfizer Recent Developments

Table 48. Hepalink Company Information, Head Office, Market Area, and Industry Position

Table 49. Hepalink Company Profile and Main Business

Table 50. Hepalink Anticoagulant Injections Models, Specifications, and Application

Table 51. Hepalink Anticoagulant Injections Revenue and Gross Margin, US$ Million, 2020-2025

Table 52. Hepalink Recent Developments

Table 53. King-friend Company Information, Head Office, Market Area, and Industry Position

Table 54. King-friend Company Profile and Main Business

Table 55. King-friend Anticoagulant Injections Models, Specifications, and Application

Table 56. King-friend Anticoagulant Injections Revenue and Gross Margin, US$ Million, 2020-2025

Table 57. King-friend Recent Developments

Table 58. CSBIO Company Information, Head Office, Market Area, and Industry Position

Table 59. CSBIO Company Profile and Main Business

Table 60. CSBIO Anticoagulant Injections Models, Specifications, and Application

Table 61. CSBIO Anticoagulant Injections Revenue and Gross Margin, US$ Million, 2020-2025

Table 62. CSBIO Recent Developments

Table 63. Amphastar Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 64. Amphastar Pharmaceuticals Company Profile and Main Business

Table 65. Amphastar Pharmaceuticals Anticoagulant Injections Models, Specifications, and Application

Table 66. Amphastar Pharmaceuticals Anticoagulant Injections Revenue and Gross Margin, US$ Million, 2020-2025

Table 67. Amphastar Pharmaceuticals Recent Developments

List of Figures

Figure 1. Anticoagulant Injections Picture

Figure 2. Global Anticoagulant Injections Consumption Value, (US$ million) & (2020-2031)

Figure 3. China Anticoagulant Injections Consumption Value, (US$ million) & (2020-2031)

Figure 4. By Consumption Value, China Anticoagulant Injections Market Share of Global, 2020-2031

Figure 5. Global Anticoagulant Injections Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 6. China Anticoagulant Injections Key Participants, Market Share, 2024

Figure 7. Anticoagulant Injections Industry Chain

Figure 8. Anticoagulant Injections Procurement Model

Figure 9. Anticoagulant Injections Sales Model

Figure 10. Anticoagulant Injections Sales Channels, Direct Sales, and Distribution

Figure 11. LMWH

Figure 12. Unfractionated Heparin

Figure 13. Fibrinolytics

Figure 14. Other

Figure 15. by Type, Global Anticoagulant Injections Consumption Value, 2020-2031, US$ Million

Figure 16. by Type, Global Anticoagulant Injections Consumption Value Market Share, 2020-2031

Figure 17. VTE

Figure 18. ACS/MI

Figure 19. AF

Figure 20. Other

Figure 21. by Application, Global Anticoagulant Injections Consumption Value, 2020-2031, US$ Million

Figure 22. by Application, Global Anticoagulant Injections Revenue Market Share, 2020-2031

Figure 23. By Region, Global Anticoagulant Injections Consumption Value Market Share, 2020-2031

Figure 24. North America Anticoagulant Injections Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 25. By Country, North America Anticoagulant Injections Consumption Value Market Share, 2024

Figure 26. Europe Anticoagulant Injections Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 27. By Country, Europe Anticoagulant Injections Consumption Value Market Share, 2024

Figure 28. Asia Pacific Anticoagulant Injections Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 29. By Country/Region, Asia Pacific Anticoagulant Injections Consumption Value Market Share, 2024

Figure 30. South America Anticoagulant Injections Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 31. By Country, South America Anticoagulant Injections Consumption Value Market Share, 2024

Figure 32. Middle East & Africa Anticoagulant Injections Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 33. United States Anticoagulant Injections Consumption Value, 2020-2031, US$ Million

Figure 34. by Type, United States Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 35. by Application, United States Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 36. Europe Anticoagulant Injections Consumption Value, 2020-2031, US$ Million

Figure 37. by Type, Europe Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 38. by Application, Europe Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 39. China Anticoagulant Injections Consumption Value, 2020-2031, US$ Million

Figure 40. by Type, China Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 41. by Application, China Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 42. Japan Anticoagulant Injections Consumption Value, 2020-2031, US$ Million

Figure 43. by Type, Japan Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 44. by Application, Japan Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 45. South Korea Anticoagulant Injections Consumption Value, 2020-2031, US$ Million

Figure 46. by Type, South Korea Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 47. by Application, South Korea Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 48. Southeast Asia Anticoagulant Injections Consumption Value, 2020-2031, US$ Million

Figure 49. by Type, Southeast Asia Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 50. by Application, Southeast Asia Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 51. India Anticoagulant Injections Consumption Value, 2020-2031, US$ Million

Figure 52. by Type, India Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 53. by Application, India Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 54. Middle East & Africa Anticoagulant Injections Consumption Value, 2020-2031, US$ Million

Figure 55. by Type, Middle East & Africa Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 56. by Application, Middle East & Africa Anticoagulant Injections Consumption Value Market Share, 2024 VS 2031

Figure 57. Research Methodology

Figure 58. Breakdown of Primary Interviews

Figure 59. Bottom-up Approaches

Figure 60. Top-down Approaches